XML 37 R25.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note 17 - Income Taxes
12 Months Ended
Mar. 31, 2016
Notes to Financial Statements  
Income Tax Disclosure [Text Block]
17.
INCOME TAXES
 
The components of income tax expense were as follows:
 
 
   
Year Ended March 31,
 
   
2016
   
2015
 
Current:
               
Federal
  $
1,817,000
    $
1,209,000
 
State
   
316,000
     
159,000
 
Foreign
   
171,000
     
(65,000
)
Total current
   
2,304,000
     
1,303,000
 
Deferred:
               
Federal
   
152,000
     
(315,000
)
State
   
(61,000
)
   
(57,000
)
Total deferred
   
91,000
     
(372,000
)
                 
Total
  $
2,395,000
    $
931,000
 
 
Income tax expense was different from the amount computed by applying the statutory federal income tax rate of
34%
as shown in the following table:
 
   
Year Ended March 31,
 
   
2016
   
2015
 
Expected Federal income tax expense U.S. statutory rate
  $
2,092,000
     
34.0
%
  $
1,161,000
     
34.0
%
State income taxes, net of Federal benefit
   
169,000
     
2.7
%
   
67,000
     
2.0
%
Permanent differences, other
   
47,000
     
0.8
%
   
42,000
     
1.2
%
Section 831(b) benefit
   
(316,000
)
   
-5.1
%
   
(364,000
)
   
-10.6
%
Change in valuation allowance
   
557,000
     
9.0
%
   
 
     
 
 
Domestic production activities deductions
   
(193,000
)
   
-3.1
%
   
(107,000
)
   
-3.1
%
Other differences, net
   
39,000
     
0.6
%
   
132,000
     
3.8
%
Income tax expense
  $
2,395,000
     
38.9
%
  $
931,000
     
27.3
%
 
Delphax, which generated a loss for the period from
November 24, 2015
through
March 31, 2016
and is
not
included in the Air T, Inc.
’s consolidated tax returns, is the source of the above valuation allowance effect. 
 
Deferred tax assets and liabilities consisted of the following as of:
 
   
March 31,
 
   
2016
   
2015
 
                 
Inventory reserves
  $
504,000
    $
115,000
 
Accrued vacation
   
439,000
     
244,000
 
Stock option compensation
   
141,000
     
47,000
 
Warranty reserve
   
74,000
     
85,000
 
Accounts and notes receivable reserve
   
181,000
     
83,000
 
Net operating loss carryforwards
   
5,353,000
     
-
 
Federal credits
   
4,784,000
     
-
 
263A inventory capitalization
   
60,000
     
145,000
 
Other
   
112,000
     
79,000
 
Total deferred tax assets
   
11,648,000
     
798,000
 
                 
Deferred Revenue
   
(52,000
)
   
-
 
Prepaid expenses
   
(563,000
)
   
(473,000
)
Property and equipment
   
(70,000
)
   
(463,000
)
Intangibles
   
(388,000
)
   
-
 
Total deferred tax liabilities
   
(1,073,000
)
   
(936,000
)
Net deferred tax (liability) asset
  $
10,575,000
    $
(138,000
)
Less Valuation Allowance
   
(10,830,000
)
   
-
 
Net deferred tax (liability) asset after Valuation Allowance
  $
(255,000
)
  $
(138,000
)
 
The deferred tax items are reported on a net current and non-current basis in the accompanying fiscal
2016
and
2015
consolidated balance sheets according to the classification of the underlying asset and liability.
 
The Company accounts for uncertain tax positions in accordance with accounting principles generally accepted in the United States of America. The Company has analyzed filing positions in all of the federal, state and international jurisdictions where it is required to file income tax returns, as well as all open tax years in these jurisdictions. The periods subject to examination for the Company
’s federal return are the fiscal
2012
through
2014
tax years. The periods subject to examination for the Company’s state returns are generally the fiscal
2011
through
2014
tax years. As of
March 31, 2016
and
2015,
the Company did
not
have any unrecognized tax benefits. The Company does
not
believe there will be any material changes in unrecognized tax positions over the next
twelve
months.
 
It is the Company
’s policy to recognize interest and penalties accrued on any unrecognized tax benefits as a component of income tax expense. As of
March 31, 2016
and
2015,
the Company did
not
have any accrued interest or penalties associated with any unrecognized tax benefits, nor was any interest expense recognized during the years ended
March 31, 2016
and
2015.
 
As described in Note
8,
effective on
November 24, 2015,
Air T, Inc. purchased interests in Delphax. With an equity investment level by the Company of approximately
38%,
Delphax is required to continue filing a separate United States corporate tax return. Furthermore, Delphax has
three
foreign subsidiaries located in Canada, France, and the United Kingdom which file tax returns in those jurisdictions. With few exceptions, Delphax is
no
longer subject to examinations by income tax authorities for tax years before
2011.
 
Delphax maintains a
September 30
fiscal year. As of
September 30, 2015,
Delphax and its subsidiaries had estimated foreign and domestic tax loss carryforwards of
$6.0
million and
$7.9
million, respectively. As of that date, they had estimated foreign research and development credit carryforwards of
$4.5
million, which are available to offset future income tax. The credits and net operating losses expire in varying amounts beginning in the year
2023.
Domestic alternative minimum tax credits of approximately
$325,000
are available to offset future income tax with
no
expiration date. The Company is currently evaluating whether the investment in Delphax by Air T resulted in an ownership change for purposes
 of Section
382.
 The Company anticipates completing this analysis prior to filing it’s
first
quarterly report for fiscal year
2017.
 Should there be an ownership change for purposes of Section
382
or any equivalent foreign tax rules, the utilization of the previously mentioned carryforwards will be significantly limited.
 
The provisions of ASC
740
require an assessment of both positive and negative evidence when determining whether it is more-likely-than-
not
that deferred tax assets will be recovered. In accounting for the Delphax acquisition on
November 24, 2015,
the Company established a full valuation allowance against Delphax
’s net deferred tax assets of approximately
$10,273,000.
The corresponding valuation allowance at
March 31, 2016
was approximately
$10,830,000.
The cumulative losses incurred by Delphax in recent years was the primary basis for the Company’s determination that a full valuation allowance should be established against Delphax’s net deferred tax assets.
 
U.S. income tax has
not
been recognized on the excess of the amount for financial reporting over the tax basis of investments in foreign subsidiaries for Delphax that is indefinitely reinvested outside the United States. This amount becomes taxable upon a repatriation of assets from the subsidiary or a sale or liquidation of the subsidiary. Determination of the amount of any unrecognized deferred income tax liability on this temporary difference is
not
practicable because of the complexities of the hypothetical calculation.